All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Paradigm Biopharmaceuticals Limited revenue reports

Paradigm Biopharmaceuticals Limited financial reports, Paradigm Biopharmaceuticals Limited annual revenue in 2024. When does Paradigm Biopharmaceuticals Limited report revenue?
Add to widgets
Added to widgets

Paradigm Biopharmaceuticals Limited total revenue, net income and dynamics of changes in Aussie dollar today

Net revenue Paradigm Biopharmaceuticals Limited is now 127 238 $. Information about net revenue is taken from open sources. Net income Paradigm Biopharmaceuticals Limited - -10 365 248 $. Information about net income is used from open sources. These are the main financial indicators of Paradigm Biopharmaceuticals Limited. Chart of online financial report of Paradigm Biopharmaceuticals Limited. The financial graph of Paradigm Biopharmaceuticals Limited displays the online status: net income, net revenue, total assets. All information on Paradigm Biopharmaceuticals Limited total revenue on this chart is created in the form of yellow bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2020 195 648.53 $ -69.19 % ↓ -15 938 206.51 $ -
30/09/2020 195 648.53 $ -69.19 % ↓ -15 938 206.51 $ -
30/06/2020 2 169 553.94 $ -4.53 % ↓ -5 531 635.47 $ -
31/03/2020 2 169 553.94 $ -4.53 % ↓ -5 531 635.47 $ -
31/12/2019 635 017.39 $ - -3 924 106.29 $ -
30/09/2019 635 017.39 $ - -3 924 106.29 $ -
30/06/2019 2 272 487.84 $ - -8 631 853.84 $ -
31/03/2019 2 272 487.84 $ - -8 631 853.84 $ -
Show:
to

Paradigm Biopharmaceuticals Limited financial report charts

The dates of the latest financial statements of Paradigm Biopharmaceuticals Limited: 31/03/2019, 30/09/2020, 31/12/2020. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Paradigm Biopharmaceuticals Limited for today is 31/12/2020. Gross profit Paradigm Biopharmaceuticals Limited is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Paradigm Biopharmaceuticals Limited is 127 238 $

Paradigm Biopharmaceuticals Limited quarterly report dates

Total revenue Paradigm Biopharmaceuticals Limited refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Paradigm Biopharmaceuticals Limited is 127 238 $ Operating income Paradigm Biopharmaceuticals Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Paradigm Biopharmaceuticals Limited is -10 355 831 $ Net income Paradigm Biopharmaceuticals Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Paradigm Biopharmaceuticals Limited is -10 365 248 $

Current assets Paradigm Biopharmaceuticals Limited is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Paradigm Biopharmaceuticals Limited is 91 359 404 $ Total assets Paradigm Biopharmaceuticals Limited refers to the total amount of assets owned by a person or entity. Total assets Paradigm Biopharmaceuticals Limited is 95 280 889 $ Current cash Paradigm Biopharmaceuticals Limited - the sum of all of the cash a company has on the date of report. Current cash Paradigm Biopharmaceuticals Limited is 85 206 421 $

31/12/2020 30/09/2020 30/06/2020 31/03/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
195 648.53 $ 195 648.53 $ 2 169 553.94 $ 2 169 553.94 $ 635 017.39 $ 635 017.39 $ 2 272 487.84 $ 2 272 487.84 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
- - - - - - - -
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
195 648.53 $ 195 648.53 $ 2 169 553.94 $ 2 169 553.94 $ 635 017.39 $ 635 017.39 $ 2 272 487.84 $ 2 272 487.84 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-15 923 726.38 $ -15 923 726.38 $ -6 321 667.24 $ -6 321 667.24 $ -3 913 265.80 $ -3 913 265.80 $ -3 505 860.24 $ -3 505 860.24 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-15 938 206.51 $ -15 938 206.51 $ -5 531 635.47 $ -5 531 635.47 $ -3 924 106.29 $ -3 924 106.29 $ -8 631 853.84 $ -8 631 853.84 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
13 220 109.99 $ 13 220 109.99 $ 6 517 940.05 $ 6 517 940.05 $ 3 318 132.19 $ 3 318 132.19 $ 3 620 015.97 $ 3 620 015.97 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
16 119 374.91 $ 16 119 374.91 $ 8 491 222.72 $ 8 491 222.72 $ 4 548 281.65 $ 4 548 281.65 $ 5 778 348.08 $ 5 778 348.08 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
140 479 518.44 $ 140 479 518.44 $ 166 636 916.98 $ 166 636 916.98 $ 118 776 555.20 $ 118 776 555.20 $ 126 865 262.11 $ 126 865 262.11 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
146 509 421.22 $ 146 509 421.22 $ 172 776 837.65 $ 172 776 837.65 $ 124 933 308.62 $ 124 933 308.62 $ 131 486 521.01 $ 131 486 521.01 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
131 018 334.90 $ 131 018 334.90 $ 159 796 865.25 $ 159 796 865.25 $ 109 071 695.93 $ 109 071 695.93 $ 111 228 295.10 $ 111 228 295.10 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 1 782 390.11 $ 1 782 390.11 $ 4 158 723.69 $ 4 158 723.69 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 3 033 628.55 $ 3 033 628.55 $ 4 158 723.69 $ 4 158 723.69 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 2.43 % 2.43 % 3.16 % 3.16 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
137 541 798.22 $ 137 541 798.22 $ 166 346 485.67 $ 166 346 485.67 $ 121 899 680.06 $ 121 899 680.06 $ 127 327 797.32 $ 127 327 797.32 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -4 527 858.48 $ -4 527 858.48 $ -3 382 736.89 $ -3 382 736.89 $

Last revenue report of Paradigm Biopharmaceuticals Limited was 31/12/2020. According to last financial report total revenue in Paradigm Biopharmaceuticals Limited was 195 648.53 Aussie dollar and changed by -69.19% since last year. Net income in Paradigm Biopharmaceuticals Limited was -15 938 206.51 $ in last quartal, net income changes to 0%.

Paradigm Biopharmaceuticals Limited stocks data

Paradigm Biopharmaceuticals Limited financials